Back
Compare AU
Compare EMKT vs. HLTH
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the VanEck MSCI Multifactor Em Markets Equity ETF (EMKT) and the VanEck Global Healthcare Leaders ETF (HLTH). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
EMKT | HLTH | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 361 | 54 |
Median incremental investment | $1,250.07 | $547.55 |
Median investment frequency | Monthly | Monthly |
Median total investment | $5,083.50 | $1,552.01 |
Average age group | > 35 | > 35 |
Key Summary
EMKT | HLTH | |
|---|---|---|
Strategy | EMKT.AX was created on 2018-04-10 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The ETF currently has 561.41m in AUM and 215 holdings. The VanEck MSCI Multifactor Emerging Markets Equity ETF (EMKT.AX) invests in a diversified portfolio of emerging markets listed securities with the aim of providing investment returns, before fees and other costs, which track the performance of the MSCI Emerging Markets Diversified MultipleFactor Index (AUD) (EMKT.AX Index). | HLTH.AX was created on 2020-09-08 by VanEck. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 50.99m in AUM and 51 holdings. The Fund aims to provide investment returns before fees and other costs which track the performance of the Reference Index in Australian dollars. |
Top 3 holdings | Taiwan Semiconductor Manufacturing Co Ltd (11.32 %) SK Hynix Inc (5.63 %) SK Square (3.21 %) | Arrowhead Pharmaceuticals Inc (2.27 %) argenx SE ADR (2.27 %) UCB SA (2.20 %) |
Top 3 industries | Information Technology (48.20 %) Consumer Discretionary (13.91 %) Financials (12.98 %) | Health Care (100.00 %) Other (9.10 %) |
Top 3 countries | China (26.35 %) Taiwan (20.98 %) Korea (20.42 %) | United States (65.74 %) Japan (10.95 %) Denmark (8.04 %) |
Management fee | 0.69 % | 0.45 % |
Key Summary
EMKT | HLTH | |
|---|---|---|
Issuer | VanEck | VanEck |
Tracking index | MSCI Emerging Markets Diversified Multiple-Factor Index - AUD | MarketGrader Developed Markets ex-Australia Health Care Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.69 % | 0.45 % |
Price | $34.09 | $11.27 |
Size | $583.389 million | $50.995 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 3.42 % | 0.61 % |
Market | ASX | ASX |
First listed date | 12/04/2018 | 09/09/2020 |
Purchase fee | $6.50 | $6.50 |
Community Stats
EMKT | HLTH | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 361 | 54 |
Median incremental investment | $1,250.07 | $547.55 |
Median investment frequency | Monthly | Monthly |
Median total investment | $5,083.50 | $1,552.01 |
Average age group | > 35 | > 35 |
Pros and Cons
EMKT | HLTH | |
|---|---|---|
Pros |
|
|
Cons |
|
|
EMKT | HLTH |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |